OM · Outset Medical, Inc.
$4.13
+0.01 (+0.24%)
At close · Jul 22
Market Cap
$76.56M
Shares
18.54M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$119.48M
+5.1%
FY2025
Net Income
-$81.65M
+36.2%
FY2025
Gross Margin
39.13%
+5.2pp
FY2025
Operating Margin
-55.83%
+43.9pp
FY2025
Diluted EPS
-$5.37
+85.5%
FY2025
Operating Cash Flow
-$46.33M
+60.2%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 (G) | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| $125M – $130M | $117.59M | $119.48M | $113.69M | $130.38M | $115.38M | $102.6M | $49.94M | $15.08M | $2.01M | |
| — | $69.8M | $72.72M | $75.13M | $101.38M | $97.54M | $94.99M | $62.97M | $32.88M | $8.12M | |
| — | $47.78M | $46.75M | $38.56M | $29M | $17.83M | $7.61M | -$13.04M | -$17.8M | -$6.12M | |
| — | — | 39.13% | 33.92% | 22.24% | 15.46% | 7.42% | -26.11% | -118.07% | -304.68% | |
| — | $21.34M | $21.24M | $38.4M | $57.31M | $48.86M | $36.74M | $28.85M | $23.33M | $22.92M | |
| — | $53.99M | $54.36M | $70.04M | $96.23M | $89.48M | $65.07M | $45.07M | $20.26M | $11.28M | |
| — | $39.68M | $37.86M | $43.5M | $45.23M | $40.52M | $36.32M | $30.51M | $8.92M | $6.25M | |
| — | — | $4.34M | $5.73M | $5.81M | $5.17M | $5.16M | $3.16M | $1.48M | $1.07M | |
| — | — | $34K | — | — | — | — | — | — | — | |
| — | $115.01M | $113.46M | $151.94M | $198.77M | $178.85M | $138.13M | $104.43M | $52.51M | $40.45M | |
| — | -$67.23M | -$66.71M | -$113.38M | -$169.77M | -$161.02M | -$130.52M | -$117.47M | -$70.31M | -$46.56M | |
| — | — | -55.83% | -99.72% | -130.22% | -139.56% | -127.21% | -235.24% | -466.29% | -2320.03% | |
| — | — | -$62.37M | -$107.65M | -$163.96M | -$155.85M | -$125.36M | -$114.31M | -$68.82M | -$45.49M | |
| — | $13.76M | $13.95M | $23.87M | $12.68M | $3.57M | $1.72M | $2.89M | $4.26M | $4.64M | |
| — | $6.96M | $7.41M | $9.76M | $10.17M | $3.29M | $498K | $526K | $2.49M | $1.71M | |
| — | -$74.03M | -$80.94M | -$127.49M | -$172.27M | -$162.66M | -$131.74M | -$121.49M | -$68.28M | -$49.76M | |
| — | $820K | $718K | $491K | $523K | $295K | $199K | $0 | $20K | $25K | |
| — | -$74.85M | -$81.65M | -$127.98M | -$172.8M | -$162.96M | -$131.94M | -$121.49M | -$68.3M | -$49.78M | |
| — | — | -68.34% | -112.57% | -132.54% | -141.24% | -128.59% | -243.3% | -452.97% | -2480.32% | |
| — | -$75.01M | -$81.52M | -$128M | -$172.17M | -$163.34M | -$132.12M | -$121.51M | -$68.22M | -$49.82M | |
| USD/shares | — | — | -$5.37 | -$36.96 | -$52.28 | -$50.70 | -$43.35 | -$72.75 | — | — |
| USD/shares | — | — | -$5.37 | -$36.96 | -$52.28 | -$50.70 | -$43.35 | -$72.75 | — | — |
| shares | — | — | 15.21K | 3463 | 3305 | 3210.7333 | 3039.2667 | 1090.5333 | 57.2K | 48.33K |
| shares | — | — | 15.21K | 3463 | 3305 | 3210.7333 | 3039.2667 | 1090.5333 | 57.2K | 48.33K |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Medical Devices median 2.10×
EV/EBIT
—
Medical Devices median 21.00×
P/E (TTM)
—
Medical Devices median 27.41×
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Product | $84,808,000 | $80,977,000 | $103,537,000 | $93,388,000 | $84,312,000 | $39,612,000 | $13,750,000 |
| Consumables Product | $54,075,000 | $51,145,000 | $42,206,000 | $28,798,000 | $19,179,000 | $6,741,000 | $1,563,000 |
| Service and Other Revenue | $34,668,000 | $32,712,000 | $26,839,000 | $21,987,000 | $18,290,000 | $10,323,000 | $1,328,000 |
| Consoles Product | $30,733,000 | $29,832,000 | $61,331,000 | $64,590,000 | $65,133,000 | $32,871,000 | $12,187,000 |
Key facts
CIK
1484612
CUSIP
690145206
13F (30d)
13 filings
13 filers
Visit website
Investor relations